Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00576888 · ClinicalTrials.gov registry record

Registry for Vascular Anomalies Associated With Coagulopathy

A clinical trial, sponsored by Medical College of Wisconsin.

Completed
Registry status
30
Enrollment target

NCT00576888: Completed study, sponsored by Medical College of Wisconsin.

NCT00576888 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00576888 has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
30 participants
Enrollment target

Study Summary

PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may appear red, brown or blue, often misdiagnosed as hemangiomas. The gastrointestinal tract, liver, and lungs are the most common internal organs involved. The severe thrombocytopenia (low platelets) is believed to be the result of platelet trapping within the skin and visceral vascular lesions. Severe and chronic gastrointestinal bleeding is common during infancy and early childhood. Although a relatively newly described entity, MLT was likely previously reported as hemangiomas, blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia. The term cutaneovisceral angiomatosis with thrombocytopenia is also a term used for this same disease. This study is a longitudinal cohort study of MLT to collect detailed clinical data on the distribution of disease, disease severity, and complications. This data will be used to create diagnostic criteria and an evaluation protocol for infants with this disease

Primary Outcome

Expand knowledge on consensus diagnostic criteria, atypical presentations and long term outcomes of patients with vascular anomalies

Interventions

  • OTHER no intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-11
Est. Completion 2019-04-05
Medical College of Wisconsin

447 total trials

What the finished NCT00576888 record still lists

NCT00576888 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.

NCT00576888 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00576888 about?

NCT00576888 is a clinical study titled "Registry for Vascular Anomalies Associated With Coagulopathy". PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may ...

What is the current status of trial NCT00576888?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-11. Estimated completion is 2019-04-05.

What interventions are being tested in trial NCT00576888?

The interventions under investigation include: no intervention (OTHER).

Who is sponsoring clinical trial NCT00576888?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00576888, the US trial registry maintained by the National Library of Medicine. NCT00576888 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.